Jefferies downgraded Danimer Scientific to Hold from Buy with a price target of 80c, down from $1.30. The unexpected announcement of a CEO transition without a long-term successor in place likely increases Danimer’s risk premium “sharply,” the analyst tells investors in a research note. The firm says that while a Department of Energy loan will likely provide a tailwind once confirmed, Danimer shares will likely remain range-bound pending a new CEO sketching a path to profitability and cash generation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNMR:
- Danimer Scientific CEO Stephen Croskrey to retire not later than 2024-end
- Danimer Scientific files $350M mixed securities shelf
- Danimer Scientific Launches New Executive Severance Plan
- Danimer Scientific Offers Insightful Update for Stakeholders
- Piper downgrades Danimer Scientific on sales growth uncertainty